Aspire Biopharma Holdings, Inc. (ASBP) Key Statistics & Financial Ratios

Aspire Biopharma Holdings, Inc. (ASBP) — Price $8.58 — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Key statistics dashboard for Aspire Biopharma Holdings, Inc. (ASBP). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management.

Stock Data

Price$8.58
Market Cap$1M
Enterprise Value-$11.2M
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio-1.07
Price / Book0.76
P/S10.14
EV/EBITDA-3.40
EV/Sales-114.45
EV/FCF1.56
P/FCF-0.14
Earnings Yield-124.08%
FCF Yield-725.92%
Dividend Yield0.00%

Profitability

Gross Margin18.35%
EBIT Margin-6466.27%
EBITDA Margin3367.37%
Operating Margin-7259.92%
Net Margin-11314.24%
Return on Equity1993.26%
Return on Assets-81.60%
Return on Invested Capital-59.81%
Return on Capital Employed-59.81%

Financial Health

Current Ratio7.99
Quick Ratio7.81
Cash Ratio7.22
Debt / Equity0.00
Debt / Assets0.00%
Net Debt / EBITDA-3.70
Interest Coverage-0.76

Per-Share Data

Revenue per share0.09
Book Value per share11.33
Cash per share11.72
FCF per share-6.92
Tangible Book Value per share11.33
Dividend per share0.00

Related companies: ANNA · BOCN · CAUD · CHAA · CSLM · FIAC · GAMC

Explore sector: Healthcare · Biotechnology

More sections of ASBP: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks